Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ABO Wind AG | AB9 | Nov 25, 2024 | 37.00 | -2.63 |
ABO-Group | 3T61 | Nov 25, 2024 | 5.10 | +0.99 |
ABOUT YOU HOLDING AG | YOU | Nov 25, 2024 | 3.23 | +0.78 |
Absa Group Limited | AU61 | Nov 25, 2024 | 9.05 | +1.12 |
ABSOLICON SOLAR COLLEC. B | ZY0 | Nov 25, 2024 | 0.37 | -7.81 |
AC Immune SA | IMR | Nov 25, 2024 | 3.14 | +2.45 |
Acacia Research Corporation | AZG2 | Nov 25, 2024 | 4.26 | +0.47 |
AcadeMedia | V8T | Nov 25, 2024 | 5.23 | -1.51 |
Acadia Healthcare Company, Inc. | 7RA | Nov 25, 2024 | 35.60 | -1.11 |
ACADIA Pharmaceuticals Inc. | DR6 | Nov 25, 2024 | 15.79 | +2.93 |
Acadia Realty Trust | WX1 | Nov 25, 2024 | 24.40 | +0.83 |
Acadian Timber Corp | 779 | Nov 25, 2024 | 11.60 | -4.92 |
Acanthe Developpement SA | ADX | Nov 25, 2024 | 0.31 | 0.00 |
Acarix | 7AC | Nov 25, 2024 | 0.02 | -22.71 |
Acast AB | 0PN | Nov 25, 2024 | 1.28 | +0.78 |
Accelerate Diagnostics | 1A80 | Nov 25, 2024 | 1.55 | -2.52 |
ACCELLERON IND. ADR/1 | ZH20 | Nov 25, 2024 | 51.00 | -8.93 |
Accent Resources NL | A2R | Nov 25, 2024 | 0.02 | 0.00 |
Accentis S.A. | D1Z | Nov 25, 2024 | 0.02 | -4.44 |
Accentro Real Estate AG | A4Y | Nov 25, 2024 | 0.23 | -21.77 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | Nov 25, 2024 | 344.50 | -0.20 |
Accesso Technology Group Plc | LQG | Nov 25, 2024 | 6.30 | +2.44 |
Acciona SA | AJ3 | Nov 25, 2024 | 119.00 | +2.85 |
Acco Brands Corporation | A3B | Nov 25, 2024 | 5.60 | +4.67 |
Accolade, Inc. | 4NE1 | Nov 25, 2024 | 3.50 | 0.00 |
Acconeer | 2LU | Nov 25, 2024 | 0.41 | -1.19 |
Accor | ACR1 | Nov 25, 2024 | 8.45 | -0.59 |
Accor SA | ACR | Nov 25, 2024 | 42.67 | -0.61 |
Accsys Technologies | 1D8 | Nov 25, 2024 | 0.51 | -1.91 |
Accuray Incorporated | XEJ | Nov 25, 2024 | 1.82 | +2.25 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.